|
Faheem Hasnain is our Executive Vice President, Oncology Rheumatology Strategic Business Unit and has served in that position since October 2007. Prior to that, Mr. Hasnain had served as Senior Vice President, Oncology Rheumatology Strategic Business Unit since February 2007 and as Senior Vice President, Oncology Strategic Business Unit from October 2004. Before joining Biogen Idec, he served as President, Oncology Therapeutics Network at Bristol-Myers Squibb from March 2002 to September 2004. From January 2001 to February 2002, Mr. Hasnain served as Vice President, Global eBusiness at GlaxoSmithKline, and prior to 2000, he served in key commercial and entrepreneurial roles within GlaxoSmithKline and its predecessor organizations, spanning global eBusiness, international commercial operations, sales and marketing.
| 